CureVac doesn't rule out accelerated approval for COVID-19 vaccine

German biotechnology firm CureVacdoes not rule out a speedy approval process for its prospective vaccine againstCOVID-19, its chief executive was quoted as saying on Sunday.The company said on Friday that it expects to put its vaccine on the market by mid-2021.Obtaining speedy approval suggests the company is pushing for an earlier release date although CEO Franz-Werner Haas did not give any details on how likely this was.